Skip to main content
Clinical Trials/NL-OMON56717
NL-OMON56717
Not yet recruiting
Phase 4

European microCirculatory Resistance and Absolute Flow Team-The Euro-CRAFT Registry Prospective evaluation of the impact of coronary themodilution on clinical outcomes in chronic coronary syndromes - Euro-CRAFT registry

CoreAalst BV0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
chronic coronary syndromes
Sponsor
CoreAalst BV
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
CoreAalst BV

Eligibility Criteria

Inclusion Criteria

  • Consecutive patients in whom physiological assessment of the microcirculatory
  • function including continuous coronary thermodilution has been performed with a
  • Pressure\-wire X within the context of routine clinical care.

Exclusion Criteria

  • . Age \<18 years
  • 2\. Unable to provide written informed consent (IC)
  • 3\. Unstable hemodynamics
  • 4\. Ongoing chest pain
  • 5\. Previous CABG
  • 6\. Moderate to severe valvular heart disease
  • 7\. Uncontrolled or recurrent ventricular tachycardia.
  • 8\. Active liver disease or hepatic dysfunction, defined as AST or ALT \> 3 times
  • 9\. Comorbidity with life expectancy \<\= 2 years.
  • 10\. Severe renal dysfunction, defined as an eGFR \<30 mL/min/1\.73 m2\.

Outcomes

Primary Outcomes

Not specified

Similar Trials